论文部分内容阅读
目的：观察ＥＬＦＰ方案治疗晚期胃癌的近期疗效和不良反应。方法：采用ＥＬＦＰ（Ｖ－Ｐ１６、ＣＦ、５－Ｆｕ、ＤＤＰ）联合化疗方案治疗晚期胃癌１６３例，可评价疗效６０例。结果：完全缓解４例（６．６７％），部分缓解２７例（４５．０％），总有效率为５１．７％。结论：ＥＬＦＰ方案治疗晚期胃癌有较好近期疗效，应用简捷方便、安全，值得临床推广应用。
Objective: To observe the short-term efficacy and adverse reactions of ELFP regimen in the treatment of advanced gastric cancer. Methods: 163 patients with advanced gastric cancer were treated with ELFP (V-P16, CF, 5-Fu, DDP) combined chemotherapy regimen. The efficacy was evaluated in 60 patients. Results: Complete remission in 4 cases (6.67%), partial remission in 27 cases (45.0%), the total effective rate was 51.7%. Conclusion: The ELFP regimen has good short-term efficacy in the treatment of advanced gastric cancer. It is simple, convenient and safe to use. It is worthy of clinical application.